Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee
Completed
- Conditions
- Osteoarthritis in the Knee
- Registration Number
- NCT04369261
- Lead Sponsor
- LG Chem
- Brief Summary
This is an observational study to evaluate the injection site reactions of Synovian® Inj. in patients with osteoarthritis in the knee
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1949
Inclusion Criteria
- Adult male or female patient of over 19 years of age
- A patient diagnosed with knee osteoarthritis
- A patient who has been informed of the purpose, method of the study and signed the written informed consent form.
Exclusion Criteria
- A patient who shows hypersensitive reaction to the Synovian® Inj. or to the ingredients of Synovian® Inj.
- A patient with infection at the joint
- A patient with skin infection or skin disease at the injection area
- A patient diagnosed with osteoarthritis with the Kellgren & Lawrence Grade IV in X-ray within 12 months before enrollment of this study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety endpoints Week 2 injection site reactions
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hanyang University GURI Hospital
🇰🇷Guri-si, Gyeonggi-do, Korea, Republic of